Anakinra-responsive lichen planus in a woman with Erdheim-Chester disease: a therapeutic enigma.

Anakinra is a recombinant form of interleukin-1 receptor antagonist. It is the drug of choice for Schnitzler syndrome and cryopyrin-associated periodic syndromes. It has also recently been demonstrated to have activity in the treatment of the non-Langerhans cell histiocytosis known as Erdheim-Chester disease.
To describe the activity of anakinra in a patient with co-existing lichen planus and Erdheim-Chester disease.
A 43-year-old woman with progressive Erdheim-Chester disease presented for management of her night sweats and chills, systemic skeletal bone pain, and neurologic (diabetes insipidus) manifestations. She also had widespread cutaneous lichen planus. Anakinra, 100 mg subcutaneously daily, was initiated for the treatment of her Erdheim-Chester disease.
Within 2 days of starting anakinra, there was prompt resolution of her Erdheim-Chester disease-related symptoms. Subsequently, her bone pain resolved and her diabetes insipidus improved. Also, the lichen planus-associated pruritus rapidly ceased and most of the skin lesions improved.
Our experience confirms the efficacy of anakinra for the treatment of Erdheim-Chester disease. The concomitant improvement of her lichen planus on anakinra suggests that this agent warrants additional study in this disorder.
AuthorsPhilip R Cohen, Razelle Kurzrock
JournalDermatology online journal (Dermatol Online J) Vol. 20 Issue 1 Pg. 21241 (Jan 2014) ISSN: 1087-2108 [Electronic] United States
PMID24456945 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Interleukin 1 Receptor Antagonist Protein
  • Human Growth Hormone
  • Vitamin D
  • Progesterone
  • levocetirizine
  • Deamino Arginine Vasopressin
  • Thyroxine
  • Cetirizine
  • Adult
  • Cetirizine (therapeutic use)
  • Deamino Arginine Vasopressin (therapeutic use)
  • Diabetes Insipidus (drug therapy, etiology)
  • Drug Eruptions (drug therapy, etiology)
  • Erdheim-Chester Disease (complications, drug therapy, radionuclide imaging)
  • Female
  • Human Growth Hormone (deficiency, therapeutic use)
  • Humans
  • Interleukin 1 Receptor Antagonist Protein (adverse effects, therapeutic use)
  • Lichen Planus (complications, drug therapy, pathology)
  • Progesterone (therapeutic use)
  • Pruritus (drug therapy, etiology)
  • Thyroiditis, Autoimmune (complications, drug therapy)
  • Thyroxine (therapeutic use)
  • Vitamin D (therapeutic use)
  • Vitamin D Deficiency (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: